Shots: Enterome to get $50M upfront plus $640M as milestones payments and future equity investment commitment from Takeda. The companies will jointly co-develop EB8018 and if approved, the product will be co-promoted in the US with equal profit/cost sharing Takeda to get hold of exclusive license rights for EB8018 to commercialize outside the US and […]Read More
